Simponi vs Humira
Golimumab vs Adalimumab · Comparison Guide
Quick Comparison
| Feature | Simponi | Humira |
|---|---|---|
| Generic Name | Golimumab | Adalimumab |
| Manufacturer | Janssen | AbbVie |
| Drug Class | TNF-alpha Inhibitor | TNF-alpha Inhibitor |
| Shared Conditions | Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, UC | |
Key Differences: Simponi vs Humira
Simponi is a once-monthly subcutaneous injection; Humira is every 2 weeks. Both are TNF inhibitors with similar approved indications, though Humira covers more conditions (Crohn's, HS, uveitis, pediatric arthritis). Simponi is available as an IV formulation (Simponi Aria) for RA and UC. Humira has significantly more biosimilars and post-marketing data.
💊 Simponi (Golimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: Janssen
- Full Simponi information →
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
Simponi is a once-monthly subcutaneous injection; Humira is every 2 weeks. Both are TNF inhibitors with similar approved indications, though Humira covers more conditions (Crohn's, HS, uveitis, pediatric arthritis). Simponi is available as an IV formulation (Simponi Aria) for RA and UC. Humira has significantly more biosimilars and post-marketing data.
Neither Simponi nor Humira is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Simponi and Humira are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Simponi and Humira both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Simponi and Humira
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Simponi and Humira should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.